CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q220 Q320 Q420 Q121 Q221 Q321 Q421 Q122 Q222 Revenues: Clearing and transaction fees 940.2 835.4 843.0 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 Market data and information services 134.7 139.4 139.8 144.2 145.2 145.4 142.1 151.7 151.7 Other Revenue 107.4 105.9 115.7 102.1 104.1 85.6 55.9 56.8 60.9 Total revenues 1,182.3 1,080.7 1,098.5 1,253.3 1,179.2 1,109.9 1,147.3 1,346.6 1,237.2 Expenses: Compensation and benefits 217.0 216.4 215.6 225.0 211.7 198.6 201.7 185.2 185.3 Technology 49.1 48.1 53.6 48.2 49.3 49.3 45.8 45.9 45.9 Professional fees and outside services 51.2 48.4 50.0 37.4 36.8 45.2 32.3 31.8 32.0 Amortization of purchased intangibles 76.6 78.3 79.0 60.6 59.4 59.0 58.6 58.4 57.1 Depreciation and amortization 36.7 39.7 41.5 37.6 37.1 37.2 35.9 33.5 33.0 Licensing and other fee agreements 55.4 57.7 57.9 64.7 54.2 57.6 60.4 80.9 83.1 Other expense 58.8 67.1 85.9 54.7 56.0 49.3 80.9 51.8 51.1 Operating expenses 544.8 555.7 583.5 528.2 504.5 496.2 515.6 487.5 487.5 Operating Income 637.5 525.0 515.0 725.1 674.7 613.7 631.7 859.1 749.7 Operating Margin 54% 49% 47% 58% 57% 55% 55% 64% 61% Non-operating Income and Expense Investment income 32.1 23.6 31.1 30.9 62.4 145.8 67.8 73.1 286.9 Interest and other borrowing costs (41.9) (41.7) (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) Equity in net gains (losses) of unconsolidated subsidiaries 48.8 44.0 46.6 56.2 55.7 66.4 67.5 73.3 87.3 Other non-operating income (expense) (15.2) (14.4) (16.0) (18.4) (25.0) 311.8 74.2 (46.7) (217.3) Non-operating income (expense) 23.8 11.5 20.0 27.2 51.4 482.2 167.6 57.2 117.0 Income before income taxes 661.3 536.5 535.0 752.3 726.1 1,095.9 799.3 916.3 866.7 Income taxes 158.0 125.0 110.2 177.5 215.5 169.6 174.1 205.3 204.2 Net income 503.3 411.5 424.8 574.8 510.6 926.3 625.2 711.0 662.5 Less: net income (loss) attributable to NCI - (0.2) 0.8 0.4 0.3 (0.2) - - - Net Income Attributable to CME Group 503.3 411.7 424.0 574.4 510.3 926.5 625.2 711.0 662.5 Net Income Attributable to CME Group 503.3 411.7 424.0 574.4 510.3 926.5 613.3 702.0 654.1 Effective Tax Rate 23.9% 23.3% 20.6% 23.6% 29.7% 15.5% 21.8% 22.4% 23.6% Earnings per Share: Basic EPS 1.41 1.15 1.18 1.60 1.42 2.59 1.71 1.96 1.82 Diluted EPS 1.40 1.15 1.18 1.60 1.42 2.58 1.71 1.95 1.82 Weighted average number of common stock shares: Basic Shares 357,691 357,791 358,047 358,147 358,261 358,363 358,582 358,609 358,641 Diluted Shares 358,457 358,590 358,612 358,817 358,888 358,988 359,019 359,180 359,205 Preferred Shares 2,890 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q220 Q320 Q420 Q121 Q221 Q321 Q421 Q122 Q222 Revenues: Clearing and transaction fees 940.2 835.4 843.0 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 Market data and information services 134.7 139.4 139.8 144.2 145.2 145.4 142.1 151.7 151.7 Other Revenue 107.4 105.9 115.7 102.1 101.0 85.6 55.9 56.8 60.9 Total revenues 1,182.3 1,080.7 1,098.5 1,253.3 1,176.1 1,109.9 1,147.3 1,346.6 1,237.2 Expenses: Compensation and benefits 202.7 205.5 202.6 207.5 201.9 191.1 183.7 182.8 189.5 Technology 48.5 47.3 52.2 47.7 49.2 49.1 45.6 45.8 45.9 Professional fees and outside services 42.7 40.0 39.2 27.9 30.0 26.5 27.2 30.3 31.4 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 33.7 37.0 37.2 36.8 36.7 36.7 35.6 33.5 32.9 Licensing and other fee agreements 55.4 57.7 57.9 64.7 54.2 57.6 60.4 80.9 83.1 Other expense 51.9 56.1 74.3 52.1 54.8 51.3 76.5 51.7 59.6 Operating expenses 434.9 443.6 463.4 436.7 426.8 412.3 429.0 425.0 442.4 Operating Income 747.4 637.1 635.1 816.6 749.3 697.6 718.3 921.6 794.8 Operating Margin 63% 59% 58% 65% 64% 63% 63% 68% 64% Non-operating Income and Expense Investment income 26.4 22.6 24.1 26.9 37.3 55.1 58.2 74.7 299.5 Interest and other borrowing costs (41.9) (41.7) (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) Equity in net gains (losses) of unconsolidated subsidiaries 48.8 44.0 46.6 56.2 55.7 70.5 78.7 84.7 98.2 Other non-operating income (expense) (15.2) (14.4) (16.0) (18.4) (25.0) (32.9) (33.0) (43.4) (218.5) Non-operating income (expense) 18.1 10.5 13.0 23.2 26.3 50.9 62.0 73.5 139.3 Income before income taxes 765.5 647.6 648.1 839.8 775.6 748.5 780.3 995.1 934.1 Income taxes 182.3 152.8 150.2 198.2 186.7 174.3 172.8 228.9 217.6 Net income 583.2 494.8 497.9 641.6 588.9 574.2 607.5 766.2 716.5 Less: net income (loss) attributable to NCI - (0.2) 0.8 0.4 0.3 (0.2) - - - Net Income Attributable to CME Group 583.2 495.0 497.1 641.2 588.6 574.4 607.5 766.2 716.5 Net Income Attributable to Common Shareholders of CME Group 583.2 495.0 497.1 641.2 588.6 574.4 595.7 756.6 707.5 Effective Tax Rate 23.8% 23.6% 23.2% 23.6% 24.1% 23.3% 22.1% 23.0% 23.3% Earnings per Share: Basic EPS 1.63 1.38 1.39 1.79 1.64 1.60 1.66 2.11 1.97 Diluted EPS 1.63 1.38 1.39 1.79 1.64 1.60 1.66 2.11 1.97 Weighted average number of common stock shares: Basic Shares 357,691 357,791 358,047 358,147 358,261 358,363 358,582 358,609 358,641 Diluted Shares 358,457 358,590 358,612 358,817 358,888 358,988 359,019 359,180 359,205 Preferred Shares - - - - - - 2,890 4,584 4,584 -- 2 of 2 --